Introduction
============

Zebrafish has been utilized over the past years to successfully study cellular and genetic processes regulating the development of cardiac, vascular, and lymphatic development ([@B34]; [@B23]; [@B38]). Among the several advantages of the zebrafish model system is the large number of embryos that each mating generates (an extraordinary resource for further experimental needs), external development (e.g., easy accessibility for experimental manipulation and imaging), and optical clarity. Distinctively, the optical clarity of zebrafish embryos allows to easily perform live imaging of cells and to track them in the context of a whole organism. An advantage of this feature is the use of transgenic zebrafish animals marking cardiac, blood, endothelial, and lymphatic endothelial cells with genetically encoded markers. Within the last decade, a considerable number of zebrafish fluorescent transgenic lines have been generated to better characterize different components of the vascular system, such as myocardial and endocardial cells, arteries, veins, and lymphatic tissues. The availability of tissue-specific transgenic lines and advanced microscopy techniques (i.e., light sheet and confocal microscopy), have permitted high-resolution time-lapse imaging of developing heart structures, lymphatic and blood vessels, as well as perivascular cells at the subcellular level ([@B29]; [@B27]; [@B8]). Such dynamic imaging allows for the dissection of the mechanisms underlying heart and blood/lymphatic vessel patterning, branching, and their regulation.

Furthermore, zebrafish are amenable to both forward genetic approaches (e.g., ENU mutagenesis screens), and reverse genetic studies (such as TALEN and CRISPR/Cas9) ([@B17]; [@B25]). Cre/lox recombinase-based genetics to delete genes of interest in a tissue-specific manner has also been successfully applied to study cardiovascular development and homeostasis ([@B11]). Here, we will review the most recent methods and studies on cardiac, vascular, and lymphatic development presented at the recent 2018 European Zebrafish Principal Investigators Meeting in Trento, Italy.

Recent Advancements on Cardiac, Vascular, and Lymphatic Research in Zebrafish
=============================================================================

Heart Studies
-------------

The heart is the first functional organ to form in the vertebrate embryo. While already pumping and maintaining constant blood flow, the heart undergoes profound morphogenetic changes to acquire its final shape. The periodic changes in the mechanical forces as well as intracellular calcium concentrations contribute considerably to the final organ form and function. From the specification of cardiac progenitors, the genetic programs controlling heart formation and function, to cell biological processes of heart morphogenesis, researchers in the zebrafish field have contributed significantly to our understanding of heart development over the last decade ([@B6]; [@B56]). Although several mutants affecting cardiac function have already been isolated during the first large-scale mutagenesis screens ([@B55]), the functional patterning of the developing myocardium is a less explored area of research. This is partially due to the lack of *in vivo* techniques to study action potential propagation or changes in intracellular calcium concentrations during each heartbeat. High-speed optical mapping techniques are currently limited to an *ex vivo* analysis ([@B45]), however, the growing number of fast genetically encoded voltage and calcium indicators, together with the recent advances *in vivo* imaging ([@B64]), will allow researchers to close this gap of knowledge in the very near future.

Pertaining to the functional patterning of the developing myocardium, Dr. D. Panáková expanded on already reported data showing the Wnt11 non-canonical pathway regulating the intercellular electrical coupling in the developing zebrafish heart through attenuation of the L-type calcium channel (LTCC) conductance ([@B45]). The LTCC has an important function in cardiac biology. Its conductance is regulated by membrane depolarization or by the β-adrenergic/Protein kinase A (PKA) pathway, and mediates Ca^2+^ influx. The molecular mechanisms by which Wnt11 signaling might modify LTCC, and thus regulate its activity, were unclear. The research group of Dr. Panáková found that Wnt11 signaling regulates the LTCC through its effects on the A-kinase anchoring protein (AKAP)/PKA signalosome. They further showed that the AKAP/PKA signalosome is an essential component of Wnt11 signaling regulating channel function during the establishment of intercellular electrical coupling gradients in the developing zebrafish heart.

The field of arrhythmias is indeed another exciting area where zebrafish models have been successfully applied, as demonstrated by the pioneering work of the MacRae and Saffitz groups ([@B39]; [@B35]; [@B3]). In the specific context of inherited arrhythmogenic cardiomyopathies (AC), mostly linked to defects in desmosomal components ([@B48]), Dr. Tiso's group presented the first zebrafish model for human AC type 8 (AC8), a form of AC caused by mutations in the desmosomal protein desmoplakin ([@B49]). By knocking down both zebrafish desmoplakin genes (*dspa* and *dspb*) Tiso's team could specifically phenocopy the ultrastructural features and cardiac frequency defects of AC8. Moreover, the availability of zebrafish lines, which are able to report *in vivo* the activation of a series of signaling pathways ([@B41]), was exploited in the study to analyze a set of signals known to be involved in cardiac function.

The screen allowed to identify three pathways (Wnt/beta-catenin, Hippo/YAP-TAZ, and TGFbeta), out of nine considered, that are specifically altered in AC8-like conditions ([@B19]). Interestingly, in chronic organ injury, a possible cross-talk among these signals has been recently hypothesized ([@B47]). This discovery, made in a zebrafish setup, is thus offering a new, network-wide view of AC conditions, and suggesting a set of evolutionary conserved signaling mechanisms worth to be considered in the design of a molecularly-targeted therapy for AC.

Vascular Studies
----------------

As a model system, the zebrafish offers unique advantages for studying vascular development *in vivo* ([@B23]). Recent findings have also shown that the zebrafish possesses a *bona fide* brain vascular system, making it useful for studying the formation of this distinct vascular network in the head. In Trento, Dr. Wiebke Herzog and Dr. Arndt Siekmann provided new insights on the mechanisms that govern the formation of the brain vasculature in early zebrafish embryos. It is well established that Vascular Endothelial Growth Factor A (VEGFA) is one of the main signaling molecules important for blood vessel growth and homeostasis ([@B54]). Work over the last years has provided detailed insights on the downstream signaling events that occur upon receptor activation ([@B2]). However, it has remained enigmatic how endothelial cells balance these diverse signaling outcomes in order to temporally and spatially control initiation of cell migration and proliferation. Instead of a single *VEGFA* gene, zebrafish possess two VEGFA genes, *vegfaa* and *vegfab* ([@B5]). Dr. Arndt Siekmann presented data on the different phenotypes of *vegfaa* and *vegfab* mutants. As expected, *vegfaa* mutants displayed severe brain blood vessel defects. Surprisingly, *vegfab* mutations mainly affected endothelial cell proliferation. Blood vessels could still sprout and form a relatively normal vascular architecture, despite a reduction in endothelial cell numbers. These findings indicate that proliferation and migration can be uncoupled during angiogenic blood vessel sprouting. They furthermore suggest an unexpected plasticity in terms of endothelial cell sizes when it comes to establishing vascular networks. The important next steps will be to identify *vegfab* targets mediating cell cycle progression, but not cell migration.

Another signaling pathway regulating brain blood vessel formation is Wnt signaling ([@B50]). Mutations in the Wnt pathway components Wnt7 ([@B57]), GPR124, and Reck ([@B62]; [@B59]) were previously shown to specifically interfere with brain blood vessel formation. Of note, blood vessel formation in other regions of the embryos can proceed relatively unperturbed in these mutants. This suggests that the brain vasculature requires a distinct set of molecules for its formation. One reason for this might be the necessity to also form the blood brain barrier during embryonic development that shields the brain. New results from the laboratory of Dr. Herzog now provide evidence that Wnt signaling is less required for the initial sprouting of brain blood vessels, but is rather necessary in newly connecting blood vessels. Here, Wnt signaling regulates the localization of junctional proteins in order to facilitate blood vessel anastomosis. Thus, Wnt signaling might coordinate the different steps necessary for the proper development and maturation of brain blood vessels. Further experiments will aim at a better understanding of the molecules that mediate these different effects of Wnt signaling.

Lymphatic Studies
-----------------

Mammals, zebrafish, and other vertebrates possess a second vascular system entirely separate from the blood circulatory system called the lymphatic system. The lymphatic system is a complex, blind-ended vascular network that extends into virtually every part of the body. It is essential for maintaining fluid homeostasis, absorbing dietary lipids from the intestine, and for immune cell production and trafficking ([@B7]; [@B1]). Since the first identification of zebrafish lymphatic vessels in 2006 ([@B33]; [@B67]), a number of studies have provided evidence that the zebrafish lymphatic system shares many of the morphological, molecular, and functional characteristics of lymphatic vessels in other vertebrates ([@B67]; [@B22]; [@B44]; [@B30]). The zebrafish has helped identify important molecular players in lymphangiogenesis such as *cxcr4-cxcl12* chemokine signaling, which provides guidance cues directing early trunk lymphatic development ([@B13]), and *pkd1* for polarity, elongation, and the adherens junctions for lymphatic endothelial cells that are essential for vessel morphogenesis ([@B16]). The Weinstein lab recently generated a valuable new *Tg*(*mrc1a:egfp*)*^y251^* transgenic zebrafish line for visualizing and investigating lymphatic vascular development ([@B30]). The Mannose receptor (MR, CD206 or MRC1) is a transmembrane glycoprotein that belongs to the C-type lectin family, known to be strongly expressed in macrophages, dendritic cells, and prominently in lymphatics ([@B58]). MRC1 is involved in lymphocyte migration ([@B36]). Zebrafish *mrc1a* is expressed in primitive veins and lymphatics ([@B65]; [@B30]), and this new transgenic line has proven extremely useful for studying the growth and assembly of novel major superficial and deep lymphatic vessels in the trunk that form during later stages of development ([@B30]).

In the course of using the *Tg*(*mrc1a:egfp*)*^y251^* transgenic line, the Weinstein lab researchers discovered that in addition to lymphatics, this transgenic line also displays strong EGFP expression in a novel cell population on the surface of the zebrafish brain ([@B63]). Despite expressing *mrc1a:egfp* and other lymphatic transgenes, these newly discovered brain cells are individual non-lumenized perivascular cells, associated with blood vessels located exclusively in the brain meninges. In addition to a macrophage-like morphology, these cells also contain large numbers of internal auto fluorescent vesicles or vacuoles, and they exhibit extremely robust scavenger activity as shown by rapid uptake of India Ink and other "tracers" injected into intracranial spaces or brain ventricles. Careful cell lineage and live imaging studies demonstrated that these cells emerge by transdifferentiation from the venous endothelium of the optic choroidal vascular plexus, and RNA-seq on FAC-sorted Mrc1a-positive cells revealed that despite their macrophage-like morphology and perivascular location, they appear molecularly most similar to lymphatic endothelium, strongly expressing lymphatic markers such as *lyve1, prox1a*, and *flt4* ([@B63]). The expression of a number of different lymphatic transgenes also led two other groups to contemporaneously discover and report on these cells in the zebrafish ([@B10]; [@B61]). Based on similarities in their morphology, location, and scavenger behavior, these cells appear to be the zebrafish equivalent of cells variably characterized as Fluorescent Granular Perithelial cells (FGPs), perivascular macrophages, or "Mato Cells" in mammals ([@B37]). In mammals, FGPs are found in the leptomeningeal layers surrounding blood vessels, where they are thought to provide an important pinocytotic protective function. Further study of FGPs in the experimentally and genetically accessible zebrafish model system is sure to yield important new insights into blood-brain barrier establishment, removal of toxic waste from the brain, and the relationship between brain homeostasis and waste clearance and neurodegenerative disorders and protection from brain injury and infection.

A debate has been going on in recent years, within the zebrafish community, on the use of morpholinos to study gene function, based on the published observation that mutants in several genes, obtained through reverse genetic approaches, were not sharing the same phenotypes of the corresponding morphants ([@B32]). Genetic compensation elicited in mutants, but not in morphants, rather than simply toxicity or off-target effects of morpholinos, might be at the basis of these discrepancies ([@B51]), and not only in zebrafish, but also in other model organisms where knockout and knockdown approaches are giving different results ([@B17]). [@B12] showed, through the use of morpholinos, that the transcription factor Sox18 plays a role in early zebrafish lymphatic development, suggesting an evolutionary conservation between fish and mammals. Mutations in *SOX18* underlie both recessive and dominant forms of Hypotrichosis-Lymphedema-Telangiectasia syndrome ([@B28]); the phenotypic spectrum is highly variable among patients and most, but not all of them, present with lymphedema ([@B40]; [@B66]). *Sox18*-null mice develop severe lymphedema in a pure B6 background, but show no signs of lymphatic dysfunction in a mixed background, where the upregulation of the closely related transcription factors Sox7 and Sox17 in the cardinal vein compensates for the lack of Sox18 ([@B18]; [@B24]).

[@B60] reported that in a *sox18* loss-of-function mutant thoracic duct (TD) formation was unaffected and they questioned the role of Sox18 in the regulation of lymphatic development in zebrafish. Dr. Monica Beltrame presented at the meeting data gathered in her lab on an independent *sox18*-null mutant, generated through the Zebrafish Mutation Project at Sanger ([@B31]). Homozygous *sox18* mutants showed subtle but statistically significant defects in TD formation (Moleri et al., unpublished data). A slight perturbation of VegfC signaling exacerbated TD defects in a genotype-dependent manner, unraveling differences in TD formation even in *sox18* heterozygotes versus wild types. Remarkably, an upregulated expression of *sox7* in the posterior cardinal vein was observed in *sox18* mutants, thus possibly explaining the milder lymphatic phenotypes with respect to the knockdown of *sox18*, which was not affecting *sox7* expression ([@B12]). Overall, a high degree of evolutionary conservation in the regulation of lymphatic development by SoxF TFs is thus confirmed.

Reporter Tools and Genetic Versatility for Cardiovascular Studies in the Zebrafish System
=========================================================================================

In recent years, cardiovascular research in zebrafish greatly benefited from the development of a series of innovative genetic tools, mostly represented by mutant, transgenic, and biosensor lines, allowing to analyze *in vivo* a wide range of components in physiological as well as in pathological contexts (development, signaling, contraction, regeneration, inflammation) occurring in the cardiovascular compartment. To date, several zebrafish lines have been generated to identify and perturb *in vivo* different sub-cardiac compartments, such as the endocardium, myocardium, epicardium, valves, or conduction system as well as specific vascular components and cell types including arteries, veins, lymphatic vessels, mural, and endothelial cells ([@B53]; [@B6]; [@B21]; [@B9]).

In this perspective, during the EZPM2018 in Trento, a spectacular series of new interesting systems have been presented, all worth to be reported and added to the available toolkit. In the context of new mutant and transgenic line production, the research group of Dr. Beltrame presented a new allele for Sox18, which allowed to further elucidate the role of this key factor in the development of lymphatic vessels in vertebrates. Dr. Siekmann's research group has produced new mutant lines for the two *VEGFA* paralogs (*vegfaa* and *vegfab*), elegantly demonstrating that both factors act through the same receptor (Kdrl) to induce sprouting, vessel formation, and vascular-specific gene expression. Finally, using the transgenic line *Tg*(*mrc1a:eGFP*), Dr. Weinstein's group could efficiently analyze a new population of perivascular cells *in vivo* ([@B30]).

In the field of cardiovascular signaling, Dr. Tiso's group presented the systematic application of pathway-specific transgenic lines for the identification of drugs with therapeutic effects in cardiac pathology. Specifically, a form of arrhythmogenic cardiomyopathy was modeled in a set of different zebrafish lines reporting signaling pathways activated in the cardiac compartment. This signaling-based screen allowed identifying the involved cascade, rapidly passing to the test of pathway-specific compounds, and the identification of a Wnt agonist as a potential therapeutic drug ([@B19]). The role of the canonical Wnt pathway in the vascular compartment has also been studied by Dr. Herzog's group ([@B26]). In particular, her team produced and presented a set of transgenic lines able to express in a vascular-specific way a dominant negative form of a Wnt effector (dnTcf), as well as destabilized Wnt-responsive fluorophores. With the combined use of these systems, the team could successfully inhibit Wnt signaling in a temporal and tissue-specific fashion, analyzing the response to the pathway within time frames of about 2 h. This strategy allowed to establish a new role for the Wnt pathway in the anastomosis of the capillaries during the formation of the blood brain barrier.

Challenges and Outlook
======================

Zebrafish is a long-standing model to study heart morphogenesis. With the growing number of genetic tools and technological advances, probing the functional inputs and their related physical stimuli, such as mechanical or calcium cues in greater detail *in vivo*, will soon ensue. The dysregulation of ion channels, such as LTCC, can result in arrhythmias as well as cardiac hypertrophy, both of which are underlying pathologies leading to sudden cardiac death. Future studies, in which modulation of functional inputs plays a crucial role, will therefore also accelerate novel avenues for future therapies regarding common cardiac diseases, including cardiac hypertrophy, heart failure, and arrhythmias.

Many questions still remain open in the field of vascular and lymphatic studies in zebrafish. Besides VEGF and Wnt, other signaling pathways are increasingly studied in vascular development, such as the Hippo pathway ([@B42]; [@B43]; [@B4]). Similarly, hemodynamic forces seem to play a critical role in cardiovascular development and differentiation ([@B14], [@B15]; [@B20]).

We envision a new interactive atlas of zebrafish vascular and lymphatic anatomy using modern technologies, such as light sheet microscopy and fluorescent markers of different colors. It would be a *desideratum* for researchers working in the field to also include perivascular cells, such as mural cells.

It can be expected that in the coming years the growing application of single-cell sequencing technologies and the use of reporter pathway lines, with conditional modulation, combined with mutant lines for new regulators of cardiac as well as vascular components, will allow a highly specific genetic dissection of each process, with thus far unprecedented precision in the cardiovascular research field. We expect that cutting-edge high throughput approaches, such as single-cell RNA sequencing and metabolomics will be feasible in the near future ([@B52]; [@B46]). We envision that the zebrafish model system will continue to help in understanding the genetic and molecular basis of human cardiovascular and lymphatic malformations and diseases.
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